Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This study is to determine whether efalizumab 1.0mg/kg given by subcutaneous injection for 12
weeks is effective in treating oral lichen planus.
This is a 20 week, single center, open-label pilot study to enroll 5 subjects.